ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BYSI vs CPHI // NET PROFIT MARGIN

BeyondSpring Inc. (NASDAQ) VS. China Pharma Holdings Inc. (NYSE) • 15-METRIC TALLY: BYSI 1 — CPHI 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BYSI VS. CPHI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BYSI CPHI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — -3.20% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -11.40% -23.60 CPHI /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — 0.32% — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin ACTIVE — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — -8.50% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 4/9 -2.00 CPHI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 53.4 41.1 +12.30 BYSI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $26.5M $26.9M -$411.5K CPHI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BYSI REV CPHI REV BYSI GROSS % CPHI GROSS % BYSI FCF CPHI FCF
FY 2025 $25.0M $4.1M — -3.2% -$19.8M $88.9K
FY 2024 $24.5M $4.5M — -43.8% -$16.7M -$444.5K
FY 2023 $42.2M $7.0M — — -$16.5M -$699.7K
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BYSI // BETA —
CPHI // BETA —